SVRASavara Inc.
+4.6% today · +27.8% over a year
No score: too little data.
Priced higher than most peers. No dividend.
Savara Inc. (SVRA) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €995.4M. Over the past 12 months the price changed by +27.8%, with an annualised volatility of 55% and a largest fall of 39%. Hard red flags in our rules-based screen: Heavy dilution, Financial distress.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Return on assetsweighs on the score · better than 2% of peers
- Return on invested capitalweighs on the score · better than 5% of peers
- Share issuance (1 y)weighs on the score · better than 19% of peers
Red flags and notes
- Serious warning. Share count growing more than 10 % a year over three years. More in the glossary → Share count growing more than 10 % a year over three years.
- Serious warning. Altman Z in the distress zone and negative free cash flow. More in the glossary → Altman Z in the distress zone and negative free cash flow.
- Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/B
- 10.3
- Free-cash-flow yield
- −11.8%
- Market cap (EUR)
- €995.4M
Profitability and debt
- Return on equity
- −151.0%
- Return on invested capital
- −145.2%
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +4.6%
- 1 month
- +2.6%
- 1 year
- +27.8%
- Volatility, 1 yr
- 54.8%
- Max drawdown, 1 yr
- −39.2%
- Beta
- 1.07
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| IRMDiRadimed Corporation | 6/10 | 0.9% | 4.5% |
|---|---|---|---|
| IARTIntegra LifeSciences Holdings | 4/10 | 0.0% | 19.4% |
| VSTMVerastem Inc. | 1/10 | 0.0% | 7.8% |
| ATECAlphatec Holdings Inc. | 1/10 | 0.0% | −62.7% |
| SIBNSI-BONE Inc. | 3/10 | 0.0% | 62.3% |
| MLTXMoonLake Immunotherapeutics | 1/10 | 0.0% | 18.7% |
| CBLLCeriBell Inc. | 1/10 | 0.0% | 130.4% |
| CSTLCastle Biosciences Inc. | 3/10 | 0.0% | 4.1% |
News and filings
No recent news or filings in our sources.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.